Müller-Quernheim, J

SARCOIDOSIS, especially HEARTSARCOIDOSIS, a Literature Survey:
Advanced research s. PubMed, Embase, Cochrane Central Register
of Controlled Trials.
• 1 Müller-Quernheim, J.: Sarcioidosis: clinical manifestations, staging and
therapy (part II), Respir. Med. 92 (1998) 140-ff
• 2 Müller-Quernheim, J.: Sarcoidosis: immunopathogenetic concepts and
their clinical application. Eur. Respir. J. 12 (1998) 716 – 738
• 2 Karl Wurm : Sarkoidoseleitfaden. Thieme Verlag, Stuttgart 2000. ISBN 313-108012-4
• 3 Friedrich Wilhelm Bettinger (Hrsg.) : Sarkoidoseleitfaden. Thieme Verlag,
Stuttgart 1997, ISBN 3-13-108011-6
• 4 P. Zabel : Anti – Malariamittel gegen Sarkoidose. Aus : SARKOIDOSE UPDATE 2000, Detlef Kirsten, Helge Magnussen, Interpneu-Verlag.
Aus : Sakoidose Nachrichten und Berichte Nr. 100, März 2013, Seite 18.
• 5 Sarkoidose – up date 2000 - Seite 171 - Google Books-Ergebnisseite
Google.de/books ? isbn=3831111944
• 6 S1- Leitlinie : Immunvermittelte Erkrankungen der grauen ZNS-Substanz
sowie Neurosarkoidose.
Deutsche Gesellschaft für Neurologie (DGN). In : AWMF online (Snd 2012)
• 7 Fleming HA. Sarcoid heart disease. Br Heart J 1974 ; 36 :54-68
• 8a Fleming HA . Death from sarcoid heart disease. United kingdom series
1871 to 1986. 300 cases with 138 deaths. In :Grassi C, Rizzato G, Pozzi E, eds.
Sarcoidosis and other granulomatous disorders : 11th world congress, Milan,
1987. Amsterdam : Elsevier, 1988.19-31.
• 8b CARDIAC SARCOIDOSIS. Editorial. Dr. Celia Oakley. Royal Postgraduate
Medical School, London. Thorax 1989 :44 :371-372
• 9 Salez, F., Gosset, P., Copin. M.C., Degros. C.L., Tonnel, A.B., Wallaert, B.:
Transforming growth factor 7 in sarcoidosis, Eur. Respr. J. 12 (1998) 913 – 9191
• 10 Yamamoto, M., Sharma, O.P., Hosoda, Y: Special report: The 1991
descriptive definition of sarcoidosis, Sarciodosis 9 (Suppl 1) (1992) 33 – 34
• 11 Ziegenhagen, M.W., Benner, U.K., Zissel, G.: Zabel, P., Schlaak, M., MüllerQuernheim, J.: Sarcoidosis. TNF-alpha release from alveolar macrophages and
serum level of sIL-2R are prognosstic markers. Am. J. Respir. Crit. Care Med.
156 (1997) 1587 – 1592
• 12 Zissel, G., Ernst, M., Schlaak, M. Müller-Quernheim, J.: Accessor function
of alveolar macrophages from patients with sarcoidosis and other
granulomatous and nongranulomatous lung diseases. J. Investig. Med. 45
(1997) 75 – 86
• 13 Zissel, G., Homolka, J. Schlaak, J. Schlaak, M., Müller-Quernheim, J.:
Antiinflammatory cytokine release by alveolar macrophages in pulmonary
sarcoidosis. Am. J. Respir. Crit. Care Med. 154 (1996) 713 – 719
• 14 Zheng, L., Teschler, H., Guzman, J., Hübner, K., Striz, I., Costabel, U.:
Alveolar macrophage TNF-alpha release and BAL cell phenotypes in
sarcoidosis. Am. J. Respir. Crit. Care Med. 152 (1995) 1061 – 1066
• 15 Manes, D.G., T.E. Siltzbach: A wold-wide review of sarcoidosis. Ann. N. Y.
Acad. Sci. 278 (1976) 321 – 334
• 16 Kalkoff, K.W.: Sarkoidose. In: Korting, W. (Hrsg): Dermatologie in der
Praxis und Klinik. 1. Aufl., Bd. II. Thieme, Stuttgart 1980 (S. 18.77 – 18.107)
• 17 Kirsten, D.: Sarkoidose in Deutschland. Analyse einer Fragebogenaktion
im Jahre 1992 bei Patienten der Deutschen Sarkoidose-Vereinigung.
Pneumonologie 49 (1995) 378 – 382
• 18 Müller-Quernheim, J., G. Zissel, R. Schopf, E. Vollmer, M. Schlaak:
Differentialdiagnose Berylliose / Sarkoidose bei einem Zahntechniker. Dtsch.
med. Wochenschr. 121 (1996) 1462 – 1466
• 19 Paule P, Braem L, Heno P, Miltgen J, Verrot D, Fourcade L, Bonnet D.
Diagnosis of cardiac sarcoidosis and follow-up of 24 consecutive patients, Rev
Med Interne; 2004 May; 25(5): 357 – 62
• 20 Riezzo I, Ventura F, D’Errico S, Neri M, Turillazzi E, Fineschi V.,
Arrhythmogenesis and diagnosis of cardiac sarcoidosis. An
immunohistochemical study in a sudden cardiac death. Forensic Sci Int; 2009
Jan 10; 183 (1-3): e1-5
• 21 Bussinguer M, Danielian A, Sharma OP. Cardiac sarcoidosis: diagnosis
and management. Curr Treat Options Cardiovasc Med; 2012 Dec; 14(6): 652-64
• 22 Milman N, Mortensen SA. Cardiac sarcoidosis. Ugeskr Laeger; 2006 Oct
30; 168(44): 3801-6
• 23 Nery PB, Leung E, Birnie DH. Arrhythmias in cardiac sarcoidosis:
diagnosis and treatment, Curr Opin Cardiol; 2012 Mar; 27(2): 181-9
• 24 Milman N, Andersen CB, Mortensen SA. Cardiac sarcoidosis – a difficult
diagnosis. A report of 8 consecutive patients with arrhythmias and
cardiomyopathy. Ugeskr Laeger; 2006 Oct 30; 168(44): 3822-4
• 25 Ziora D, Jastrzebski D, Labus A. Advances in diagnosis of pulmonary
sarcoidosis. Pneumonol Alergol Pol; 2012; 80(4): 355-64
• 26 Hufnagel, G.: Die Herzbeteiligung bei systemischer Sarkoidose –
Diagnostik und Therapie. http:/herz.online.uni-marburg.de/hzb16.htm.
• 27 Badorff, C., Schwimmbeck, P.L… Kardiale Sarkoidose:
Diagnosesicherung durch Endomyokardbiopsie und Therapie mit
Kortikosteroiden.
In: Zeitschrift für Kardiologie, ISSN 1435-1285, Vol. 86 (1.1997), p.9-14
• 28 C M Oakley: EDITORIAL: Cardiac sarcoidosis. Thorax 1989 44: 371-372,
doi: 10.1136/thx.44.5.371
• 29 Dirk G. Dechering et al.: Electrophysiological characteristics of
ventricular tachyarrhythmias in cardiac sarcoidosis versus ARVC. DHKG Tagung in Mannheim 2013.
• 30 Kim JS et al. Cardiac sarcoidosis. Am.Heart J 2009; 157:9 – 21.
• 31 D. Kirsten, A.-M. Kirsten: Sarkoidose. Ratgeber für Patienten. Inter-PneuVerlag. ISBN: 3-9810132-3-9.
• 32 Kim JS, Judson MA, Donnino R et al. Cardiac sarcoidosis.
Am Heart J 2009;157:9-21.
• 33 Yared K, Johri MA, Soni AV, et al. Cardiac sarcoidosis imitating
arrhythmogenic right ventricular dysplasia. Circulation 2008;118:e113 – e115.
• 34 Jason P. Evanchan, D et al.: Cardiac Sarcoidosis: Recent Advances…
The Journal of Innovation in Cadiac Rhythm Management, 4 (2013), 1160 – 1174
• 35 Sugizaki Y et al.: Isolated primary cardiac sarcoidosis presenting as acute
heart failure. Intern Med. 2013; 52(!): 71 – 4 Epub 2013 Jan 1.
• 36 Kandolin R et al. Diagnosis in isolated cardiac sarcoidosis.
J Intern Med. 2011Nov; 270(5):461 – 8.
• 37 Jonathon White, MD ChB, et al.: Isolated Primary Cardiac Sarcoidosis
Circ Heart Fail. 2010; 3: e “8-e 29.)
• 38 E. Bub: Sarkoidose: Was tun? – Das Herz im Zentrum des Geschehens!
MEDICA Düsseldorf am 20.11.1992. Sarkoidosenachrichten und Berichte
Nr. 19, Dezember 1992.
• 39 10.06.2004 E. Bub: Herzsarkoidose Teil 1 (21/04), Praktische Kardiologie,
Journal by Fax
• 40 17.06.2004 E. Bub: Herzsarkoidose Teil 2 (22/04), Praktische Kardiologie,
Journal by Fax
• 41 2004: Dr. E. Bub, Dr. H. J. Habbel: Herzsarkoidose – Eine kaum bekannte
Erkrankung mit zumeist deletärem Ausgang. Zeitschrift der Deutschen
Sarkoidosevereinigung, Nr. 66, 2004
• 42 Ernst G.Vester: SARKOIDOSE – INTERDISZIPLINÄRE SICHTWEISE zur
SYSTEMERKRANKUNG: Aus der Sicht des Kardiologen. Medica Düsseldorf
(2009).
• 43 Baughman et al; Am J Respir Crit Care Med 2001.
• 44 Iwai et al.; Sarcoidosis 1994.
• 45 W.Schulte, D. Kirsten, M. Derent, U. Costabel: Cardiac involvement in
sarcoidosis. Eur Respir Mon, 2005; 32:130.
• 46 Dubrey S.W., Falk R.H. : Diagnosis and Management of Cardiac
Sarcoidosis. Progress in Cardiovascular Diseases 52 (2010)336 – 346
• 47 Greulich S et al.: „CMR imaging predicts death and other adverse
events in suspected cardiac sarcoidosis“. JACC Cardiovasc Imaging.
2013 Apr; 6(4):501 – 11.
• 48 Doughan AR et Williams BR: Cardiac sarcoidosis, Heart 2006
92(2): 282-8.
• 49 Habersberger et al.: Cardiac sarcoidosis. Intern Med J 2008;
38(4): 270-7.
• 50 Mehta D et al.: Cardiac involvement in patients with sarcoidosis:
diagnostic and prognostic value of outpatient testing.
• 51 Ladyjanskaia GA et al. : Sarcoid myocarditis with ventricular tachycardia
mimicking ARVD/C. J Cardiovasc Electrophysiol 2010;21:94-98.
• 52 Jannuzzi MC: Genetics of sarcoidosis. Semin Respir Crit Care Med.
2007 Feb; 28(1): 15-21.
• 53 Butany J et al.: The intricacies of cardiac sarcoidosis: a case report
involving the coronary arteries and a review of the literature. Cardiovasc
Pathol 2006;15: 222-7.
• 54 Lam CSP et al.: Coronary sarcoidosis presenting as acute coronary
syndrome. Clin Cardiol 2008 (in press).
• 55 Nelson JE et al.: Sarcoidosis presenting as heart disease.
Sarcoidosis Vasc Diffuse Lung Dis 1996;13:178-82.
• 56 Gibbons WJ et al.: Subclinical cardiac dysfunction in sarcoidosis.
Chest 1991;100:44-50.
• 57 Yazaki Y et al. Prognostic determinants of longterm survival
in Japanese patients with cardiac sarcoidosis treated with prednisone.
Am J Cardiol 2001; 88:1006-10.
• 58 Chiu CZ et al. Prevention of left ventricular remodeling by long-term
corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol
2005;95:143-6.
• 59 Mueller-Quernheim et al. Treatment of chronic sarcoidosis with an
azathioprine/prednisolone regimen. Eur Respir J 1999;14:1117-22.
• 60 Baughman RP, Costabel U, du Bois RM. Treatment of sarciodosis.
Cli Chest Med 2008;29:533-48.
• 61 Zaidi AR et al. Outcome of heart transplantation in patients with
sarcoid cardiomyopothy. J Heart Lung Transplant 2007;26:714-7.
• 62 Yager J et al. Recurrece of cardiac sarcoidosis in a heart transplant
recipient. J Heart Lung Transplant 2005;24:1988-90.
• 63 Uthman I et al. Cardiac sarcoidosis to monotherapy with infliximab.
Clin Rheumatol 2007;26:2001-3.
• 64 Evanchan JP et al. Cardiac Sarcoidosis: Recent Advances in Diagnosis
and Treatment and an Argument for the Need for a Systematic Multidisciplinary
Approach to Management. J In Card Rhythm Management, 4 (2013), 11601174.
• 65 Kandolin R et al. Cardiac sarcoidosis and giant cell myocarditis
as causes of atrioventricular block in young and middle-aged adults.
Circ Arrhythm Electrophysiol 2011;4:303-309.
• 66 Hiraga H et al. Guideline for the Diagnosis of Cardiac Sarcoidosis
Study Report on Diffuse Pulmonary Diseases (in Japanese).
Tokyo: Japan: The Japanese Ministry of Health and Welfare; 1993:23.24.
• 67 Vignaux O.: Cardiac Sarcoidosis: spectrum of MRI features.
AJR Am J Roentgenol 2005; 184:249-254.
• 68 Crouser ED et al. The CD4+ lymphopenic sarcoidosis phenotype
is highly responsive to anti-tumor necrosis factor-(alpha) therapy.
Chest 2010;137:1432-1435.
• 69 Mehta D et al. Primary prevention of sudden cardiac death in silent
cardiac sarcoidosis. Role of programmed ventricular stimulation. Circ
Arrhythm Electrophysiol 2011;4:43-48.
• 70 Dhadham GC et al. Cardiac sarcoidosis with a rare initial Manifestation:
sustained monomorphic ventricular tachycardia. Tex Heart Inst J; 2011; 38(1):
74-6.
• 71 Chau EM et al. Cardiac sarcoidosis: a potentially fatal but treatable form
of infiltrative heart disease. Hong Kong Med J 12: 65-67, 2006.
• 72 Lopez JA et al.: Cardiac sarcoidosis. An unusual form of acute
congestive cardiomyopathy. Tex Heart Inst J 22: 265-267, 1995.
• 73 Greulich S. et al. CMR imaging predicts death and other adverse events
in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6, 501 –
511.
• 74 Dubrey SW, Falk RH: Diagnosis and management of cardiac sarcoidosis.
Prog Cardiovasc Dis. 2010 Jan-Feb; 52(4): 336-46.
• 75 Vakil, K et al.: Right Ventricular Sarcoidosis: Is It Time for
Updated Diagnostic Criteria? Tex Heart Inst J 2014;41(2):203-7.
References and literature: Appendage 1 – 24 Isolated Right Ventricular
Sarcoidosis mimicking ARVC.
• 76 Mantini N et al. Cardiac sarcoid: a clinician´s review on how to approach
the patient with cardiac sarcoid. Lin Cardiol. 2012;35(7):410-5.
• 77 Bagwan IN , Hooper LV, Sheppard MN. Cardiac sarcoidosis and sudden
death. The heart may look normal or mimic other Cardiomyopathies.
Virchows Arch. 2011 Jun;458(6): 671-8.
• 78 Youssef G et al. The use of 18F-FDG PET in the diagnosis of cardiac
sarcoidosis: a systematic review and metaanalysis including the Ontario
experience. J Nucl Med. 2012 Feb;53(2): 241-8.
• 79 Sadek MM et al. Corticosteroid therapy for cardiac sarcoidosis: a
systematic review. Can J Cardiol. 2013 Sep;29(9):1034-41.
• 80 Sugizaki Y et al. Isolated primary cardiac sarcoidosis presenting as
acute heart failure. Intern Med. 2013;52(1):71-4.
• 81 Nery PB et al. Isolated cardiac sarcoidosis: establishing the diagnosis
with electroanatomic mapping-guided endomyocardial biopsy.
Can J Cardiol. 2013 aug;29(8):1015.e1-3.
• 82 Brauner KU , Wintersperger B. MRI in cardiac sarcoidosis and
amyloidosis. Radiologe.2013 Jan;53(1): 54-60.
• 83 Chang TI et al. Isolated cardiac sarcoidosis in heart transplantation.
Transplant Proc. 2012 May;44(4):903-6.
• 84 Nery PB et.al. Arrhythmias in cardiac sarcoidosis: diagnosis and
treatment. Curr Opin Cardiol.2012 Mar;27(2):181-9.
• 85 Duke C, Rosenthal E. Sudden death caused by cardiac sarcoidosis in
childhood. J Cardiovasc Electrohysiol. 2002 Sep;13(9):939-42
• 86 Dorfman T et al. Sarcoidosis masquerading as an acute coronary
syndrome. Cardiol Rev. 2005 Sep-Oct;13(5):256-9.
• 87 Sadek MM et al. Corticosteroid therapy for cardiac sarcoidosis: a
systematic review. Can j Cardiol. 2013 Sep;29(9):1034-41.
• 88 Kandolin R. et al. Diagnosing isolated cardiac sarcoidosis.
Journal of Internal Medicine, 270: 461-468.
• 89 Schatka I, Bengel FM: Advanced Imaging of Cardiac Sarcoidosis.
J Nucl Med. 2014; 55: 99-106.
• 90 Galati G, Leone O, Rapecci C. The difficult diagnosis of isolated
cardiac sarcoidosis: usefullness of an integrated MRI and PET approach.
Heart.2014;100(1): 89-90.
• 91 Yazaki Y. The diagnostic dilemma of isolated cardiac sarcoidosis.
Intern Med. 2013;52(1):1-2.
• 92 Nunes H et al. Cardiac sarcoidosis. Semin Respi Crit Care Med. 2010
Aug;31(4):428-41.
• 93 Köllermann J, Roos G, Helpap B. Sudden cardiac death from
unrecognized cardiac sarcoidosis. Pathologe. 2001 Mar;22(2): 141-4.
• 94 A. Hinz, E. Brähler, R. Möde, et al. Anxiety and depression in sarcoidosis:
the influence of age, gender, affected organs, concomitant diseases and
dyspnea. SARCOIDOSIS VASCULITIS and DIFFUSE LUNG DISEASES:
Volume 29, No 2 (2012).
• 95 M A Spruit et al.: Skeletal muscle weakness in patients with sarcoidosis
and its relationship with exercise intolerance and reduced health status.
Thorax 2005; 60: 32-38.
• 96 Betty Chang et al. Depression in Sarcoidosis. Journal of Respiratory and
Critical Care Medicine, Vo. 163, No.2 (2001) pp. 329-334.
• 97 Arianna Goracci et al. Quality of life, anxiety and depression in
Saecoidosis.
General Hospital Psychiatry: Volume 30, Issue 5, Pages 441-445, SeptemberOctober, 2008.
• 98 Wilsher, Margaret L.: Psychological stress in sarcoidosis.
Current Opinion in Pulmonary Medicine: September 2012 – Volume 18 – Issue
5 – p 524-527.
• 99 Marjolein Drent et al.: Sarcoidosis-associated fatique.
Eu Repir J 2012; 40: 255-263.
• 100 Ingrid H.E. Korenromp et al.: Characterization of Chronic Fatique in
Patients with Sarcoidosis in Clinical Remission. Chest. 2011;140(2):441-447.
• 101 R.M. Wirnsberger et al.: Evaluation of quality of life in sarcoidosis
patients. Respir Med. 1998 May; 92 (5): 750-6.
• 102 Tavee JO, Stern, BJ. NEUROSARCOIDOSIS.
Continuum (Minneao Minn). 2014 Jun;20(3 Neurology of Systemic Disease):
545-59.
• 103 Stjepanovic MI et al.: Treatment of neurosarcoidosis – innovations and
challenges. Med Pregl. 2014 May – Jun;6785-69: 161-6.
• 104 Stjepanovicv MI et al. : Radiological presentation of neurosarcoidosis.
Med Pregl. 2014 Jan – Feb ;67(1-2):24-7.
• 105 Werynska B. et al.: Neurosarcoidosis.—case report.
Pol Merkur Lekarski. 2014 May;36(215):341-4.
• 106 Beste C, Kneiphof J, Woitalla D. : Modulatory effects of proinflammatory
cytokines for action cascading progress – Evidence from Neurosarcoidosis.
Brain Behav Immun. 2014 May 17. pii: S0889-1591(14)00127-5.
• 107 Kapoor S.: Psychosis: a rare but serious psychiatric anomaly in patients
with SARCOIDOSIS. Sarcoidosis Vasc Diffuse Lung Dis. 2014 Apr !8;31(1):
76-7.
• 108 Abdallah T et al.: Isolated dysphagia unmasking bulbar
neurosarcoidosis and pulmonary sarcoidosis. Arab J Gastroenterol.2014
Jun;15(2):85-7.
• 109 Lassner D et al. Improved diagnosis of idiopathic giant cell myocarditis
and cardiac sarcoidosis by myocardial gene expression profiling. Eur Heart J;
35(32):2186-2115.